4//SEC Filing
Townsend Richard Nolan 4
Accession 0001415889-25-001287
CIK 0001907108other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:55 PM ET
Size
7.7 KB
Accession
0001415889-25-001287
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-07+207,500→ 207,500 totalExercise: $7.33Exp: 2035-01-06→ Common Stock (207,500 underlying) - Award
Common Stock
2025-01-07+103,750→ 224,445 total
Footnotes (3)
- [F1]The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Includes 147,500 RSUs.
- [F3]25% of the shares underlying the option vest and become exercisable on January 7, 2026, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001995218
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:55 PM ET
- Size
- 7.7 KB